CRIS Current Research Information System

BARUZZI, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.952
EU - Europa 6.125
AS - Asia 5.740
AF - Africa 338
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 8
Totale 20.461
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.870
CN - Cina 1.534
GB - Regno Unito 1.527
SG - Singapore 1.476
VN - Vietnam 1.426
DE - Germania 1.042
IT - Italia 851
SE - Svezia 639
HK - Hong Kong 503
NL - Olanda 459
UA - Ucraina 355
FR - Francia 335
IN - India 314
RU - Federazione Russa 296
BR - Brasile 206
IE - Irlanda 200
ZA - Sudafrica 119
JP - Giappone 98
EE - Estonia 97
CI - Costa d'Avorio 87
KR - Corea 72
TG - Togo 61
FI - Finlandia 59
JO - Giordania 53
CA - Canada 50
CH - Svizzera 50
AR - Argentina 38
BG - Bulgaria 38
SC - Seychelles 38
AT - Austria 35
UZ - Uzbekistan 32
BE - Belgio 31
PH - Filippine 31
BD - Bangladesh 25
ES - Italia 23
MX - Messico 21
GR - Grecia 20
TR - Turchia 20
IQ - Iraq 17
EU - Europa 16
ID - Indonesia 16
PL - Polonia 16
TH - Thailandia 15
SA - Arabia Saudita 14
IR - Iran 13
TW - Taiwan 13
LB - Libano 12
LT - Lituania 12
RO - Romania 12
MY - Malesia 10
PK - Pakistan 8
DZ - Algeria 7
EC - Ecuador 7
KZ - Kazakistan 7
AU - Australia 6
AZ - Azerbaigian 6
CL - Cile 6
ET - Etiopia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
NG - Nigeria 5
VE - Venezuela 5
CO - Colombia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
PE - Perù 4
PT - Portogallo 4
AL - Albania 3
BQ - ???statistics.table.value.countryCode.BQ??? 3
DK - Danimarca 3
KE - Kenya 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
CZ - Repubblica Ceca 2
EG - Egitto 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
MC - Monaco 2
MN - Mongolia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
Totale 20.453
Salva come PNG Salva come JPEG
Città #
Southend 1.306
Singapore 948
Ashburn 911
Fairfield 750
Chandler 643
Hong Kong 465
Houston 394
Ann Arbor 393
Frankfurt am Main 380
Wilmington 373
San Jose 360
Seattle 356
Woodbridge 347
Ho Chi Minh City 341
Eygelshoven 338
Santa Clara 278
Princeton 257
Cambridge 245
Jacksonville 245
Hanoi 241
Beijing 196
Dublin 195
Dong Ket 193
Hefei 174
Boardman 149
Los Angeles 141
Nanjing 129
Padova 120
Westminster 120
Lauterbourg 108
Bologna 106
Abidjan 87
Tokyo 86
Berlin 75
Jinan 75
Milan 75
Saint Petersburg 72
Buffalo 69
Turin 66
Lomé 61
Seoul 59
Helsinki 56
Shenyang 53
Amman 52
Dallas 51
Florence 50
New York 49
Dearborn 45
Washington 45
Nanchang 44
Haiphong 43
Rome 43
Changsha 42
Medford 41
Da Nang 39
Hebei 39
Guangzhou 38
Sofia 38
Bengaluru 34
Mülheim 34
San Diego 33
Tianjin 32
Bern 31
Brussels 31
Shanghai 31
Mahé 30
Norwalk 25
Hangzhou 24
Redwood City 24
Jiaxing 23
London 23
Phoenix 23
Zhengzhou 23
Bremen 22
Redondo Beach 22
Toronto 21
Haikou 20
Redmond 20
Can Tho 19
Council Bluffs 19
São Paulo 19
Verona 19
Biên Hòa 18
Des Moines 18
Johannesburg 18
Olalla 18
Yubileyny 17
Chengdu 16
Falkenstein 15
Orem 15
Falls Church 14
San Francisco 14
Vienna 14
Fuzhou 13
Montreal 13
Nha Trang 13
Ningbo 13
Chicago 12
Düsseldorf 12
Pune 12
Totale 13.562
Salva come PNG Salva come JPEG
Nome #
A new potential biomarker for dementia with Lewy bodies 910
Messenger RNA processing is altered in autosomal dominant leukodystrophy 278
Aura uditiva in pazienti con epilessia uditiva 277
Autonomic innervation in multiple system atrophy and pure autonomic failure. 272
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 272
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 264
Clinical features and long term outcome of epilepsy in periventricular nodular heterotopia. Simple compared with plus forms. 257
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 253
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 250
Defective Mitochondrial Adenosine Triphosphate Production in Skeletal Muscle From Patients With Dominant Optic Atrophy Due to OPA1 Mutations 241
Small fiber neuropathy in female patients with fabry disease. 237
Brain diffusion-weighted imaging in Friedreich's ataxia. 229
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 222
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 220
Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. 218
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 217
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? 216
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 213
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 209
A new case of Sando syndrome and retinitis pigmentosa with novel combination of compound heterozygous POLG mutations. 208
Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? 205
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 202
Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 202
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 198
Mesial temporal lobe epilepsy (MTLE): prognostic factors 196
Endozepines in recurrent stupor. 194
Attività nervosa simpatica ed ipersonnia in pazienti con Sindrome delle Apnee Ostruttive nel Sonno. 194
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 194
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 191
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 189
Idebenone treatment in Leber's hereditary optic neuropathy. 188
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). 187
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number 187
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 186
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 185
Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity. 184
Prognostic factors in patients with mesial temporal lobe epilepsy 183
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 181
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 181
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 178
Severe impairment of Complex I-driven adenosine triphosphate synthesis in leber hereditarfy optic neuropathy cybrids 177
Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. 177
Lateralizing value of the auditory aura in partial seizures. 177
A wide range of 3243A>G/tRNALeu(UUR) (MELAS) mutation loads may segregate in offspring through the female germline bottleneck. 177
Preganglionic sudomotor nerve fiber lesion in a patient with Multiple System Atrophy and generalized anhidrosis. 176
Anidrosi generalizzata: differenti sedi lesionali evidenziate attraverso la biopsia cutanea e la microneurografia. 176
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. 171
Un anno di follow-up nei pazienti con epilessia parziale che hanno completato il passaggio da carbamazepina a excarbazepina. 170
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 169
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 169
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 169
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. 167
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 166
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 166
The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. 165
Effetto della CPAP e della terapia chirurgica sull'attività simpatico muscolare e sulla pressione arteriosa in un paziente con OSAS ed ipertensione. 164
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 164
Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients. 163
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 163
Attività nervosa simpatico muscolare e pressione arteriosa in pazienti Tilt positivi e Tilt negativi con sincope vasovagale. 161
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. 161
Melanopsin retinal ganglion cell loss in Alzheimer's disease 160
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 160
Attività nervosa simpatico muscolare in un paziente affetto da sindrome di Eaton-Lambert ed ipertensione arteriosa. 158
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 158
Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 156
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 153
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 153
Progetto Neurooncologia Emilia Romagna - PERNO 152
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 151
Muscle and skin sympathetic activities in Ross syndrome 151
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 149
Focal myoclonus and dystonia associated with celiac disease. 148
Anhidrosis in patients trated with Topiramate. 145
Fattori prognostici in 170 pazienti con epilessia temporale mesiale (ETM) 145
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 143
Extreme variability in genotype/phenotype correlation in an Italian family carrying the mtDNA A3243G/tRNALeu(UUR) MELAS mutation. 143
Esagerata inibizione dell'attività simpatica indotta da stimoli di arousal in pazienti fobici con sincope vasovagale. 139
Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. 139
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 139
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine 138
Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene 138
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. 138
Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy. 137
"Plus" features of Leber's Hereditary Optic Neuropathy in nineteen Italian families. 136
POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. 135
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. 134
Prognostic factors in patients with mesial temporal lobe epilepsy (MTLE). 133
Levetiracetam therapy in patients with brain tumour and epilepsy 133
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 132
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 132
Polyneuropathy in patients with mitochondrial disorders: clinical, electrophysiological and genetic evaluations. 132
Corrigendum: Messenger RNA processing is altered in autosomal dominant leukodystrophy [Human Molecular Genetics, 24 (2015) (2746-2756)] DOI:10.1093/hmg/ddv034 131
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 130
Il monitoraggio terapeutico dei farmaci antiepilettici 127
Microneurographic evaluation of sympathetic activity in small fiber neuropathy. 126
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 125
Arousal induces exaggerated inhibition of sympathetic nerve activity in phobic patients with a history of vasovagal syncope. 124
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. 124
Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy 122
Totale 18.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021662 0 0 0 0 0 0 0 0 0 98 97 467
2021/20222.439 179 81 161 175 198 133 72 130 76 275 539 420
2022/20232.555 260 370 149 313 165 199 79 150 458 59 228 125
2023/2024820 54 122 80 84 100 208 42 41 24 30 10 25
2024/20252.343 73 290 189 184 490 136 163 50 28 159 48 533
2025/20265.814 439 446 496 414 700 683 1.076 168 1.049 343 0 0
Totale 20.749